. China’s Sinopharm becomes first non-Western vaccine to win WHO approval « JO LEE MAGAZINE

THE SYDNEY MORNING HERALD/The World Health Organisation has made its long-awaited decision on China’s Sinopharm COVID-19 vaccine, approving the jab for emergency use in all adults, meaning it can be rolled out globally.

The WHO said that based on the available data, the vaccine was 79 per cent effective against symptomatic and hospitalised cases of the disease for all ages. Clinical trials run by the state-owned company Sinopharm also showed that it had an efficacy rate of 79 per cent.

More at The Sydney Morning Herald

Comments are closed.